1) Parkinson's disease
帕金森病
1.
Effect of Salidroside on PI3K/protein kinase B signaling in Parkinson's disease model mice;
红景天甙对帕金森病模型小鼠PI3K/蛋白激酶B信号转导途径的影响
2.
Progression of MRI study on olfactory dysfunction of Parkinson's disease;
帕金森病嗅觉障碍的MRI研究进展
2) Parkinson disease
帕金森病
1.
Expression of Caspase 3 on Parkinson disease model;
帕金森病模型黑质Caspase 3的表达
2.
Proteome Analysis of Mononuclear Cell in Peripheral Blood between Patients with Parkinson Disease and Healthy Subjects;
帕金森病和正常人外周血单个核细胞的蛋白质组差异分析
3.
Regulatory strategies of stimulus parameters of deep brain stimulation in Parkinson disease;
帕金森病病人脑深部电刺激器刺激参数调节策略
3) PD
帕金森病
1.
Cost-effectiveness analysis of PD’s pharmacotherapy;
帕金森病药物治疗的成本效果评价
2.
The clinical research on fractionated irradiation treatment with X knife in patients of PD;
X刀分次治疗帕金森病的临床应用
3.
EXPERIMENTAL STUDY ON EXPRESSION OF GDNF IN PD RATS INDUCED BY 6-OHDA;
6-羟基多巴胺对帕金森病大鼠GDNF表达影响的实验研究
4) Parkinsons disease
帕金森病
1.
Effects of echinacoside on protein expression from substantia nigra and striatal tissue in mouse MPTP model of Parkinsons disease by using 2-dimensional electrophoresis analysis;
松果菊苷对帕金森病模型小鼠黑质纹状体蛋白表达影响的双向电泳分析
2.
Effect of Tortoises shell on behavior and striatum levels of dopamine in rat model of Parkinsons disease;
龟板对帕金森病大鼠行为和脑内多巴胺水平的影响
3.
The activity change of dopamine D2 receptors in caudal-putamen of Parkinsons disease model rats;
帕金森病大鼠模型尾壳核多巴胺D2受体活性变化研究
5) Parkinsonism
[英]['pɑ:kɪnsnz dɪzi:z] [美]['pɑrkɪnsṇz dɪ'ziz]
帕金森病
1.
The Treatment Experience of 14 Cases Involving Femoral Neck Fracture Accompanied with Parkinsonism;
帕金森病合并股骨颈骨折14例治疗体会
2.
According to the original texts,by analyzing the symptoms of "Diejue" and comparing with the symptoms of Parkinsonism,it is considered that Zhang Zhongjing recorded precisely the main symptoms of Parkinsonism.
结合原文,分析跌蹶的症状,并将其与帕金森病比较,认为张仲景准确地记载了帕金森病的主要症状。
3.
[Objective] To study effective method for disordered sports of parkinsonism.
[目的]探讨提高帕金森病运动障碍的有效办法。
6) Parkinson's disease
帕金森氏病
1.
Clinical data suggested their involvement in the pathogenesis of several cognition disorders,for example Alzheimer's disease(AD),Parkinson's disease(PD)and epilepsy.
临床资料提示,nAChR与一些认知功能障碍性疾病的发病机制有关,如:阿尔茨海默病(AD)、帕金森氏病(PD)以及癫痫等。
2.
Parkinson's disease (PD) characterised pathologically by the selective loss of dopaminergic neurons and the presence of Lewy bodies (LB) in the substantia nigra is the second most common neurodegenerative disorder after Alzheimer's disease, affecting people in mid and late life.
帕金森氏病(Parkinson’s disease，PD)是一种常见的神经退行性疾病，其特征是黑质多巴胺能神经元选择性减少以及路易小体(Lewy body，LB)小体形成，多见于老年人。
补充资料：抗帕金森氏病药
分子式：
CAS号：
性质：又称抗帕金森氏病药。其主要病理改变是黑质内多巴胺(DA)神经元变性坏死，使纹状体内DA功能降低而乙酰胆碱(Ach)功能相对增强而出现病症。因而抗帕金森氏病药主要分为拟多巴胺(拟DA)药，如左旋多巴、金刚烷胺、溴隐亭等和中枢抗胆碱药，如苯海索开马君等。此外如卡比多巴是一种外周性脱羧酶抑制剂，在外周抑制左旋多巴脱羧，降低外周DA的生成，与左旋多巴合用，可提高疗效，降低剂量，减少副作用。
CAS号：
性质：又称抗帕金森氏病药。其主要病理改变是黑质内多巴胺(DA)神经元变性坏死，使纹状体内DA功能降低而乙酰胆碱(Ach)功能相对增强而出现病症。因而抗帕金森氏病药主要分为拟多巴胺(拟DA)药，如左旋多巴、金刚烷胺、溴隐亭等和中枢抗胆碱药，如苯海索开马君等。此外如卡比多巴是一种外周性脱羧酶抑制剂，在外周抑制左旋多巴脱羧，降低外周DA的生成，与左旋多巴合用，可提高疗效，降低剂量，减少副作用。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条